Very long chain acyl-CoA dehydrogenase deficiency Report

Very long chain acyl-CoA dehydrogenase deficiencyVery long chain acyl-CoA dehydrogenase deficiency (VLCAD) report is used to identify genetic variants associated with a rare inherited disorder that affects the body's ability to convert certain fats to energy, causing muscle weakness, low blood sugar, and other symptoms. This report tests for genetic variants in the ACADVL gene, which encodes an enzyme that is involved in the breakdown of fatty acids.3 or more genes analyzed It is recommended if: This report is designed for individuals with a family history of VLCAD deficiency or for those who have symptoms of the condition, such as low energy, muscle weakness, and recurrent episodes of low blood sugar. Early diagnosis through genetic testing can help inform treatment and management decisions, including dietary modifications and avoidance of fasting. It can also inform family planning decisions and provide reassurance for unaffected family members. List of main conditions: Very long c